Sino Biopharmaceutical Limited (SBP GROUP) is a leading innovation and development (R&D)-driven pharmaceutical group in China, with business covering the entire industry chain of R&D, manufacturing, and commercialization of innovative drugs, biological products. It holds a dominant position in four major therapeutic areas: oncology, hepatology/cardiometabolic diseases, respiratory/autoimmune diseases, and surgery/analgesia.
Go to the websiteCountries
- China